Back to the directory

Verge Genomics

We use human data and AI to develop better drugs faster.

Founded
2015
Status
Active
Stage
Growth
Team size
50
Location
San Francisco, CA, USA
Category
Biotech & Drug Discovery
Sector
Drug Discovery and Delivery

About Verge Genomics

Verge uses artificial intelligence and human data to develop better drugs faster. Verge has an end-to-end technology-driven drug discovery and development platform, featuring one of the field’s largest and most comprehensive proprietary patient genomics datasets from human tissue. Verge uses machine learning to mine this data and develops these insights into new drugs using it’s human-centric biology and chemistry platforms.

Clinical trials

2 registered trials with this company as lead sponsor, 2024.

Phases
Phase 1 (2)
Status
Completed (1), Terminated (1)
Conditions
Healthy Volunteers, Amyotrophic Lateral Sclerosis

NCT06286475, NCT06215755

Source: ClinicalTrials.gov.

Company data compiled and maintained by Healthcare Discovery.